Join The Discussion

 

Two from Fort Worth appointed by Gov. Abbott to university boards

Steve Hicks, a University of Texas System regent who has been a vocal opponent of regents who have criticized the system’s flagship campus in Austin, was reappointed to the board by Gov. Greg Abbott on Thursday. 

read more >

Fort Worth draws closer to deal with Lancaster developer

City staff are planning to introduce the developer Feb. 3 at a meeting of the City Council's Housing and Economic Development Committee.

read more >

Compass BBVA names Happel CEO for Fort Worth

BBVA Compass has appointed Brian Happel, most recently the Fort Worth city president, its chief executive officer of Fort Worth.

read more >

Museum District: Area’s evolution creating more interaction, public spaces

Fifteen years ago if someone had shot a cannon from Fort Worth’s world-renowned museum district, nobody would have noticed, joked Lori Eklund, senior deputy director of the Amon Carter Museum of American Art. But that has changed.

read more >

Energy Transfer Partners, Regency Energy announce $18B merger

Energy Transfer Partners LP of Dallas and Regency Energy Partners LP have entered into a definitive merger agreement.

read more >

 

Novartis names new leader for Alcon as Buehler retires

Jeff George 

Swiss drug maker Novartis International AG has appointed new heads of its Fort Worth-based eye care division Alcon and generics division Sandoz, the group’s second and third largest businesses after pharmaceuticals.


Jeff George, who joined Novartis in January 2007 and previously led Sandoz, will replace retiring Kevin Buehler as head of Alcon, effective May 1, Novartis said on April 9.


Richard Francis will become head of Sandoz, the company added. Francis previously had leadership roles in sales and commercial divisions of Sanofi and Wyeth.


Under George’s leadership, Sandoz grew from $7.5 billion in sales in 2009 to $9.2 billion in 2013. He also oversaw Sandoz’ expansion to 164 countries globally, where it has more than 26,000 associates.


The three Alcon businesses – surgical, pharmaceutical and vision care – generated net sales of $10.5 billion in 2013. Alcon has more than 24,000 employees worldwide, with operations in 75 countries and products available in 180 markets.


-Betty Dillard
bdillard@bizpress.net
 

< back

Email   email
hide
Catch
How 'bout them Cowboys?